Zobrazeno 1 - 10
of 824
pro vyhledávání: '"Histiocytic lymphoma"'
Publikováno v:
Turkish Journal of Pharmaceutical Sciences, Vol 18, Iss 1, Pp 75-79 (2021)
Turk J Pharm Sci
Turk J Pharm Sci
Objectives Probucol is a bisphenol antioxidant with antiinflammatory, antilipidemic and antidiabetic effect. Development and progression of cancer is closely related to chronic inflammation and oxidative stress. Agents that target these processes hav
Publikováno v:
Journal of Breast Cancer
Histiocytic sarcoma is a rare hematologic malignancy, with very few cases of primary histiocytic sarcoma of the breast described in English scientific literature. Herein, we describe a case of primary histiocytic sarcoma of the breast in a 75-year-ol
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 46, Iss 1, Pp 41-45 (2010)
O linfoma B intravascular de grandes células (IVLBCL) é uma doença rara caracterizada pela proliferação neoplásica de células linfoides no interior de capilares. Relatamos um caso de IVLBCL em paciente jovem do sexo feminino com comprometiment
Externí odkaz:
https://doaj.org/article/96d4ebf9759f415d80503f9755ace191
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 890, p 890 (2021)
Pharmaceutics, Vol 13, Iss 890, p 890 (2021)
Since their identification over twenty-five years ago, the plethora of cell-penetrating peptides (CPP) and their applications has skyrocketed. These 5 to 30 amino acid in length peptides have the unique property of breaching the cell membrane barrier
Autor:
Matthew R. Burnett, Sigrid Carle
Publikováno v:
The FASEB Journal. 34:1-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fu-Bao Chang, Yanru Qin, Hai-Yun Guo, Weijie Zhang, Qingli Wei, Zhiwei Chang, Zhi-Jun Chang, Min Song
Publikováno v:
Oncology Letters
The aim of the present study was to determine the changes to the expression levels of fragile histidine triad (FHIT), breast cancer type 2 susceptibility protein (BRCA2), MutL homolog 1 (MLH1) and tumour protein 53 (p53) exhibited by families with a
Autor:
Kubo, T., Motoyama, K., Ikebe, T., Hosseini, B., Moosavi-Nejad, H., Hide, Takuichiro, Nejad-M., S., Akiyama, Hidenori, Hosseini, Hamid
Publikováno v:
平成27年度衝撃波シンポジウム 講演論文集 = Proceedings of the Symposium on Shock Waves in Japan, FY2015.
平成27年度衝撃波シンポジウム (2016年3月7日-9日. 熊本大学 黒髪南地区)熊本市, 熊本県
Symposium on Shock Waves in Japan, FY2015 (March 7-9, 2016. Kumamoto University), Kurokami Chuo-ku, Kumamoto, Japan
資料
Symposium on Shock Waves in Japan, FY2015 (March 7-9, 2016. Kumamoto University), Kurokami Chuo-ku, Kumamoto, Japan
資料
Publikováno v:
International Journal of Hematology. 93:247-252
We present a 62-year-old Chinese woman with histiocytic sarcoma (HS) and diffuse large B cell lymphoma (DLBL) located in the stomach. HS showed abundant eosinophilic cytoplasm with large, pleomorphic nuclei. Tumor giant and multinucleated cells were
Publikováno v:
Pediatric Blood & Cancer. 61:1874-1876
Histiocytic sarcoma (HS) is a malignant tumor composed of proliferating cells of histiocytic origin. True HS is exceedingly rare, particularly in pediatric patients. These tumors are frequently aggressive, and outcome for patients with HS has traditi